|
Robert Conrad has always had a sincere passion for medical research in combination
with product development. Considering that his background includes a family of
doctors and nurses with a history rich in medical discovery, it is no wonder that
the creation of Zeno Corporation and the groundbreaking Zeno™ evolved from his efforts.
After he read an article on heat shock response, and after the unfortunate appearance
of a large pimple before an important board meeting, Conrad began work in 1997 on
the early stages of what became the first Zeno prototype. In late 2002, during lab
testing conducted with the assistance of Dr. Charles Conrad, M.D. (Robert’s brother,
a highly acclaimed neuro-oncologist at M.D. Anderson Cancer Center in Houston, Texas
and chief medical officer of Zeno Corporation), in only two weeks of initial lab research, it
was confirmed that the technology behind Zeno wiped out 90 percent of acne-causing
bacteria in a single two-and-a-half-minute treatment. The result was the birth of
Zeno, a revolutionary new home-based medical device for over-the-counter treatment
of acne.
As the founder and chief operating officer for Zeno Corporation, Conrad oversees all clinical
research and product development, including FDA approval.
Before he founded Zeno Corporation, Conrad’s entrepreneurial positions included president, CEO, and
owner of a company that provided biologic testing services. He also previously served as
founder, owner, and vice president of operations of Iatro Research, Inc., a biotech
company primarily focused on microbiology and genetic engineering. His professional
experience includes previous executive-level management positions in the financial
industries. He has also filed 15 U.S. patents.
Conrad earned a B.S. in economics from Texas A&M University. Out of the office, Conrad
enjoys spending time with his wife and two children and competing in triathlons.
 Zeno
Press Kit
Be sure to visit us in
the near future for updates,
news, and the latest on
Zeno.
For all media inquiries,
please contact Allison
M. Allison at Richards/Gravelle,
214-891-5212 or allison_allison@richards.com.
|
